Release Date: 01/05/23 10:26 Summary: RMS: BRB Takeover Lodgement of s630(2)(b) 630(4) and 650F Price Sensitive: Yes Download Document 405.27KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%